Skip to main content
RAPS 2024 Global Regulatory Strategy Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Pharma/Biologics

Thinking Beyond Regulatory Approval: The What, Why, When, and How of Pharma Lifecycle Management

Thursday, March 7, 2024
11:45 AM – 12:45 PM East Coast USA Time
Location: Concourse B
As drug discovery and development become more and more expensive - as well as risky - pharma companies have a clear need to maximize the value of every launched product. This can be achieved through proactive and well planned lifecycle management (LCM) strategies and tactics, but making the right LCM choices is not always straightforward. This presentation focuses on the options available to LCM practitioners, and provides insights into how to optimize LCM decision making to maximize product value.

Learning Objectives:

  • Understand the ABCs of pharma lifecycle management: what it is, how to do it, and why
  • Proactively consider the 4 Ws of pharma lifecylce management: What, Why, When, and hoW
  • Pick with discernment from the pharma lifecycle management "buffet" of options to maximize product value